Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...